Several types of mutation are identified and described in the chapter. These include (1) promoter mutation, (2) splice site mutation, (3) missense mutation, (4) frameshift mutation, and 5) nonsense mutation. Match the following mutation descriptions with the type(s) of mutations listed above. More than one mutation type might match a description.
A mutation that produces a protein that is shorter than the wild-type protein but does not have any amino acid changes in the portion produced.
17. Mutation, Repair, and Recombination
Types of Mutations
- Open Question
- Open Question
Several types of mutation are identified and described in the chapter. These include (1) promoter mutation, (2) splice site mutation, (3) missense mutation, (4) frameshift mutation, and 5) nonsense mutation. Match the following mutation descriptions with the type(s) of mutations listed above. More than one mutation type might match a description.
A mutation that produces a mutant protein that differs from the wild-type protein at one amino acid position. - Open Question
Several types of mutation are identified and described in the chapter. These include (1) promoter mutation, (2) splice site mutation, (3) missense mutation, (4) frameshift mutation, and 5) nonsense mutation. Match the following mutation descriptions with the type(s) of mutations listed above. More than one mutation type might match a description.
A mutation that produces about 5% of the wild-type amount of an mRNA. - Open Question
Several types of mutation are identified and described in the chapter. These include (1) promoter mutation, (2) splice site mutation, (3) missense mutation, (4) frameshift mutation, and 5) nonsense mutation. Match the following mutation descriptions with the type(s) of mutations listed above. More than one mutation type might match a description.
A mutation that changes several amino acids in a protein and results in a protein that is shorter than the wild-type product. - Open Question
A glycine residue is in position 210 of the tryptophan synthetase enzyme of wild-type E. coli. If the codon specifying glycine is GGA, how many single-base substitutions will result in an amino acid substitution at position 210? What are they? How many will result if the wild-type codon is GGU?
- Open Question
Refer to Figure 13.7 to respond to the following:
A base-substitution mutation that altered the sequence shown in part (a) eliminated the synthesis of all but one polypeptide. The altered sequence is shown here:
5'-AUGCAUACCUAUGUGACCCUUGGA-3'
Determine why. - Open Question
Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of-function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain-of-function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently being used in clinical trials involves the 'addition' to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?
- Open Question
A significant number of mutations in the HBB gene that cause human β-thalassemia occur within introns or in upstream noncoding sequences. Explain why mutations in these regions often lead to severe disease, although they may not directly alter the coding regions of the gene.
- Open QuestionUsing the adenine–thymine base pair in this DNA sequence...GCTC......CGAG...Give the sequence after a transversion mutation.
- Open QuestionUsing the adenine–thymine base pair in this DNA sequence...GCTC......CGAG...Give the sequence after a transition mutation.
- Open QuestionThe partial amino acid sequence of a wild-type protein is… Arg-Met-Tyr-Thr-Leu-Cys-Ser …The same portion of the protein from a mutant has the sequence… Arg-Met-Leu-Tyr-Ala-Leu-Phe …Give the sequence of the wild-type DNA template strand. Use A/G if the nucleotide could be either purine, T/C if it could be either pyrimidine, N if any nucleotide could occur at a site, or the alternative nucleotides if a purine and a pyrimidine are possible.
- Open QuestionThe partial amino acid sequence of a wild-type protein is… Arg-Met-Tyr-Thr-Leu-Cys-Ser …The same portion of the protein from a mutant has the sequence… Arg-Met-Leu-Tyr-Ala-Leu-Phe …Identify the type of mutation.
- Open Question
Speculate on how improved living conditions and medical care in the developed nations might affect human mutation rates, both neutral and deleterious.
- Open QuestionThe two DNA and polypeptide sequences shown are for alleles at a hypothetical locus that produce different polypeptides, both five amino acids long. In each case, the lower DNA strand is the template strand:allele A₁ 5′. . . ATGCATGTAAGTGCATGA. . . 3′3′. . . TACGTACATTCACGTACT. . . 5′A₁ polypeptide N–Met–His–Val–Ser–Ala–Callele A₂ 5′. . . ATGCAAGTAAGTGCATGA . . . 3′3′. . . TACGTTCATTCACGTACT . . . 5′A₂ polypeptide. N–Met–Gln–Val–Ser–Ala–CBased on DNA and polypeptide sequences alone, is there any way to determine which allele is dominant and which is recessive? Why or why not?
- Open QuestionMany human genes are known to have homologs in the mouse genome. One approach to investigating human hereditary disease is to produce mutations of the mouse homologs of human genes by methods that can precisely target specific nucleotides for mutation.Despite the homologies that exist between human and mouse genes, some attempts to study human hereditary disease processes by inducing mutations in mouse genes indicate there is little to be learned about human disease in this way. In general terms, describe how and why the study of mouse gene mutations might fail to produce useful information about human disease processes.